248 related articles for article (PubMed ID: 25476122)
1. Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.
Muller KE; Tafe LJ; de Abreu FB; Peterson JD; Wells WA; Barth RJ; Marotti JD
Hum Pathol; 2015 Feb; 46(2):327-33. PubMed ID: 25476122
[TBL] [Abstract][Full Text] [Related]
2. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
D'Alfonso TM; Ross DS; Liu YF; Shin SJ
J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
[TBL] [Abstract][Full Text] [Related]
3. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
6. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
Lien HC; Huang CS; Yang YW; Jeng YM
APMIS; 2016 May; 124(5):356-64. PubMed ID: 26860948
[TBL] [Abstract][Full Text] [Related]
7. Accuracy and clinical implications of pre-operative breast core needle biopsy diagnoses of fibroepithelial neoplasms and sarcomatoid carcinomas.
Ware AD; Argani P; Cimino-Mathews A
Breast Cancer Res Treat; 2019 Nov; 178(1):51-56. PubMed ID: 31332664
[TBL] [Abstract][Full Text] [Related]
8. Recurrent angio-fibroma of breast masquerading as phyllodes tumor.
Chaurasia JK; Alam F; Shadan M; Naim M
J Cancer Res Ther; 2015; 11(3):650. PubMed ID: 26458623
[TBL] [Abstract][Full Text] [Related]
9. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
Korula A; Varghese J; Thomas M; Vyas F; Korula A
Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
[TBL] [Abstract][Full Text] [Related]
10. A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma.
Yeong J; Thike AA; Young Ng CC; Md Nasir ND; Loh K; Teh BT; Tan PH
Pathology; 2017 Dec; 49(7):786-789. PubMed ID: 29066183
[No Abstract] [Full Text] [Related]
11. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
Zhang Y; Kleer CG
Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
[TBL] [Abstract][Full Text] [Related]
12. Focal Anomalous Expression of Cytokeratin and p63 in Malignant Phyllodes Tumor: A Comparison With Spindle Cell Metaplastic Carcinoma.
Bansal M; Chen J; Wang X
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):198-201. PubMed ID: 28968268
[TBL] [Abstract][Full Text] [Related]
13. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Metaplastic Breast Carcinoma: Keratin OSCAR Versus Other Cytokeratins.
Galera P; Khan A; Kandil D
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):622-626. PubMed ID: 26371435
[TBL] [Abstract][Full Text] [Related]
15. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
16. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
Lee AH
Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
[TBL] [Abstract][Full Text] [Related]
18. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
19. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
[TBL] [Abstract][Full Text] [Related]
20. The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast.
Genco IS; Hackman K; Morrar D; Jin C; Santagada E; Hajiyeva S
Pathol Int; 2021 Jun; 71(6):415-419. PubMed ID: 33730427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
